vimarsana.com
Home
Live Updates
Intas Pharmaceuticals Ltd and Henlius Biotech enter into Exc
Intas Pharmaceuticals Ltd and Henlius Biotech enter into Exc
Intas Pharmaceuticals Ltd and Henlius Biotech enter into Exclusive License Agreement to commercialise serplulimab – A Novel Anti-PD1 mAb in Europe & India
Pti: Intas Pharmaceuticals Ltd and Henlius Biotech enter into Exclusive License Agreement to commercialise serplulimab – A Novel Anti-PD1 mAb in Europe & India
Related Keywords
India ,
,
Indian Railways ,
Press Trust Of India ,
Cintas ,
Pharmaceuticals ,
Ltd ,
Hand ,
Henlius ,
Biotech ,
Center ,
Into ,
Exclusive ,
License ,
Agreement ,
To ,
Commercialise ,
Serplulimab ,
A ,
Novel ,
Anti ,
Pd1 ,
Smab ,
In ,
Europe ,